Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

BACKGROUND: ASPirin in Reducing Events in the Elderly, a randomized, double-blind, placebo-controlled trial of daily low-dose aspirin (100 mg) in older adults, showed an increase in all-cause mortality, primarily due to cancer. In contrast, prior randomized controlled trials, mainly involving younge...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeil, John J, Gibbs, , *Peter, Orchard, Suzanne G, Lockery, Jessica E, Bernstein, Wendy B, Cao, Yin, Ford, Leslie, Haydon, Andrew, Kirpach, Brenda, Macrae, Finlay, McLean, Catriona, Millar, Jeremy, Murray, Anne M, Nelson, Mark R, Polekhina, Galina, Reid, Christopher M, Richmond, Ellen, Rodríguez, Luz Maria, Shah, Raj C, Tie, Jeanne, Umar, Asad, van Londen, G J, Ronaldson, Kathlyn, Wolfe, Rory, Woods, Robyn L, Zalcberg, John, Chan, Andrew T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936068/
https://www.ncbi.nlm.nih.gov/pubmed/32778876
http://dx.doi.org/10.1093/jnci/djaa114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936068/
https://www.ncbi.nlm.nih.gov/pubmed/32778876
http://dx.doi.org/10.1093/jnci/djaa114

Ejemplares similares